BACE1 and Down syndrome: Alic et al. [102] investigated the role of β-secretase (BACE) in patients with Down syndrome (DS) with AD, revealing that the β-secretase activity of BACE1 correlates directly with αβ levels, whereas BACE2 activity does not.